Health Condition 1: null- Pain management in patients with meniscus tear and associated knee osteoarthritis undergoing knee arthroscopy Health Condition 2: S832- Tear of meniscus, current injury
Conditions
Interventions
Intervention1: Not Applicable as it is a observational disease registry: NA
Sponsors
Sanofi IndiaLimited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient is 30-55 years of age 2. Patient with meniscal tear and associated radiographic evidence of knee osteoarthritis (with documented Kellgren-Lawrence (KL )grade I/II/III) and undergoing knee arthroscopy 3. Signed Informed consent obtained prior to any study related procedures
Exclusion criteria
Exclusion criteria: 1. Patients undergoing arthroscopy for indications other than meniscal surgeries 2. Are currently enrolled in, or discontinued within the last 30 days from, a clinical trial involving an investigational product or concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Management of pain for the study duration of one year (the different classes of drugs, their route of administration and duration used for pain management )Timepoint: The study visits where the primary end point data will be collected are baseline, v2 at one&half months, v3 at three months, v4 at six months and v5 (EOS) at one year. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cartilage damage would be determined using the Outerbridge classification at the time of arthroscopy . Mean change in VAS score at the end of the study as compared to baselineTimepoint: The study visits where the secondary end point data will be collected are baseline, v2 at one&half months, v3 at three months, v4 at six months and v5 (EOS) at one year | — |
Countries
India
Contacts
Public ContactMs Shraddha Bhatia
Sanofi India Limited
Outcome results
None listed